Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

3 Stocks Retirees Should Absolutely Love


Dividend stocks can practically be a retiree's best friend. At least, the right ones can be. Three Motley Fool contributors were asked to identify healthcare Dividend stocks they think retirees should absolutely love now. Here's why they picked (NYSE: ABBV), Gilead Sciences (NASDAQ: GILD), and Pfizer (NYSE: PFE).

Prosper Junior Bakiny (AbbVie): Retirees are usually attracted to steady dividend payers. AbbVie fits that description quite well. With 51 years of consecutive payout increases under its belt, the drugmaker has earned a place in the select group of companies known as the Dividend Kings. In the past decade alone, its management has raised its dividends by an impressive 270%.

The company has been able to sustain these increases thanks to its solid underlying business. AbbVie bears might point out that its key asset through this period was Humira, a blockbuster immunology medicine that has now lost patent exclusivity and sales of which are declining. The company expects its top line to sink this year and next as a result.

Continue reading


Source Fool.com

AbbVie Inc. Aktie

176,36 €
-0,61 %
Die AbbVie Inc. Aktie hat heute leichte Verluste von -0,61 % aufzuweisen.
Überwältigendes Buy-Interesse für AbbVie Inc.: 33 Buy-Einschätzungen ohne eine einzige Sell-Einschätzung.
Ein positives, aber moderates Potenzial für AbbVie Inc. mit einem Kursziel von 180 € im Vergleich zu 176.36 €.
Like: 0
PFE
Teilen

Kommentare